Publications

SSRN

August 2021
Article

Multiple Imputation Using Gaussian Copulas

By: F.M. Hollenbach, I. Bojinov, S. Minhas, N.W. Metternich, M.D. Ward and A. Volfovsky

Missing observations are pervasive throughout empirical research, especially in the social sciences. Despite multiple approaches to dealing adequately with missing data, many scholars still fail to address this vital issue. In this paper, we present a simple-to-use... View Details

Keywords: Missing Data; Bayesian Statistics; Imputation; Categorical Data; Estimation

Research Summary

Executive Compensation

By: Tatiana Sandino

Professor Sandino’s other stream of research examines players that influence the design of an executive’s compensation. She has examined the role shareholder activists can play in influencing CEO pay and found that a compensation-related shareholder proposal could... View Details

January 2017
Article

The Dark Side of Going Abroad: How Broad Foreign Experiences Increase Immoral Behavior

By: Jackson G. Lu, Jordi Quoidbach, F. Gino, Alek Chakroff, William W. Maddux and Adam D. Galinsky

Due to the unprecedented pace of globalization, foreign experiences are increasingly common and valued. Past research has focused on the benefits of foreign experiences, including enhanced creativity and reduced intergroup bias. In contrast, the present work uncovers a... View Details

Keywords: Moral Sensibility; Globalization; Behavior

Research Summary

Understanding Customers

In conventional business case studies, protagonists almost never have the option of stepping back to seek a new understanding of the customer. But to be effective in practice, managers need both the self-assurance and ability to initiate and pursue, with rigor and... View Details

Research Summary

Design Driven Innovation

By: Roberto Verganti

Firms, managers and scholars have often balanced between two approaches to innovation: user centered (where incremental innovation is pulled by the market) and technology push (where innovation comes from breakthrough development in technologies). However there is a... View Details

17 Jul 2012
First Look

First Look: July 17

research had taken root. Over the past 35 years, examination of social and environmental influences on creativity has become increasingly vigorous, with broad implications for the psychology of human performance, and with applications to... View Details

Keywords: Sean Silverthorne

12 Mar 2008
Working Paper Summaries

Allocating Marketing Resources

Keywords: by Sunil Gupta & Thomas J. Steenburgh

2023
Working Paper

PRIMO: Private Regression in Multiple Outcomes

By: Seth Neel

We introduce a new differentially private regression setting we call Private Regression in Multiple Outcomes (PRIMO), inspired the common situation where a data analyst wants to perform a set of l regressions while preserving privacy, where the covariates... View Details

Keywords: Analytics and Data Science; Mathematical Methods

Article

Four Things No One Will Tell You About ESG Data

By: Sakis Kotsantonis and George Serafeim

As the ESG finance field and the use of ESG data in investment decision-making continue to grow, the authors seek to shed light on several important aspects of ESG measurement and data. This article is intended to provide a useful guide for the rapidly rising number of... View Details

2022
Article

Exploring Counterfactual Explanations Through the Lens of Adversarial Examples: A Theoretical and Empirical Analysis.

By: Martin Pawelczyk, Chirag Agarwal, Shalmali Joshi, Sohini Upadhyay and Himabindu Lakkaraju

As machine learning (ML) models become more widely deployed in high-stakes applications, counterfactual explanations have emerged as key tools for providing actionable model explanations in practice. Despite the growing popularity of counterfactual explanations, a... View Details

Keywords: Machine Learning Models; Counterfactual Explanations; Adversarial Examples; Mathematical Methods

30 Dec 2014
Working Paper Summaries

Return on Political Investment in the American Jobs Creation Act of 2004

Keywords: by Hui Chen, Katherine Gunny & Karthik Ramanna

October 2000 (Revised April 2001)
Case

Cost of Capital at Ameritrade

By: Mark L. Mitchell and Erik Stafford

Ameritrade Holding Corp. is planning large marketing and technology investments to improve the company's competitive position in deep-discount brokerage by taking advantage of emerging economies of scale. In order to evaluate whether the strategy would generate... View Details

Keywords: Developing Countries and Economies; Asset Pricing; Cash Flow; Cost of Capital; Investment; Marketing; Mathematical Methods; Competition; Information Technology; Internet and the Web; Financial Services Industry

Educators

Purchase

26 Jul 2011
First Look

First Look: July 26

PublicationsPolicy Bundling to Overcome Loss Aversion: A Method for Improving Legislative Outcomes Authors:Katherine L. Milkman, Mary Carol Mazza, Lisa L. Shu, Chia-Jung Tsay, and Max H. Bazerman Publication:Organizational Behavior and... View Details

Keywords: Sean Silverthorne

November 2004 (Revised March 2007)
Case

10 Uncommon Values®: Optimizing the Stock-Selection Process

By: Paul M. Healy and Boris Groysberg

In 2003, Steve Hash, research director at Lehman Brothers, prepared to initiate the firm's "Ten Uncommon Values" stock-picking process for the year. An investment committee had to pick the 10 best stocks from about 100 stock ideas presented by the firm's analysts. The... View Details

Keywords: Stocks; Investment; Financial Strategy; Decision Making; Groups and Teams; Financial Services Industry; United States

Educators

Purchase

2001
Chapter

Publicly Funded Science and the Productivity of the Pharmaceutical Industry

By: Rebecca Henderson and Ian Cockburn

U.S. taxpayers funded $14.8 billion of health related research last year, four times the amount that was spent in 1970 in real terms. In this paper we evaluate the impact of these huge expenditures on the technological performance of the pharmaceutical industry. While... View Details

Keywords: Public Sector; Science-Based Business; Research and Development; Sovereign Finance; Pharmaceutical Industry